Adjuvant and neoadjuvant chemotherapy for patients with resectable liver metastases from colorectal cancer;La chimiothérapie à visée curative avant (neoadjuvante), ou aprés (adjuvante) la chirurgie des métastases hépatiques des cancers colo-rectaux

Bulletin de l'Academie Nationale de Medecine

Volumn 187, Issue 5, 2003, Pages 881-892

  Rougier, Philippe ^a   Guimbaud, Rosine ^b   Mitry, Emmanuel ^b   Vaillant, Jean Nicolas ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

^b Fed Transversale C ^*

Author keywords

Chemotherapy, adjuvant; Colorectal neoplasms; Hepatectomy; Neoplasms metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; COLORECTAL CARCINOMA; EVALUATION; HUMAN; LIVER METASTASIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RISK FACTOR; SURVIVAL RATE; ADJUVANT THERAPY; CARCINOMA; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; DRUG ADMINISTRATION; LIVER RESECTION; LIVER TUMOR; METASTASIS; METHODOLOGY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MULTICENTER STUDIES; NEOADJUVANT THERAPY; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 1842851046     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33972-x     Document Type: Article

References (41)

1. FONG Y., COHEN M., FORTNER J., et al. - Liver resection for colorectal metastases. J Clin Oncol, 1997, 15, 938-946.
2. NORDLINGER B., GUIGUET M., VAILLANT J.C., et al. - Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer, 1996, 77, 1254-62.
3. GUIMBAUD R. - Quelle est la place de la chimiothérapie néoadjuvante, adjuvante et palliative dans la prise en charge des métastases hépatiques d'origine colorectale ? Gastroenterol Clin Biol, 2003, 27, B63-B79.
4. AMBIRU S., MIYAZAKI M., ITO H., NAKAGAWA K., SHIMIZU H., NAKAJIMA N. - Adjuvant regional chemotherapy after hepatic resection for colorectal metastases. Br J Surg, 1999, 86, 1025-31.
5. FIGUERAS J., VALLS C., RAFECAS A., FABREGAT J., RAMOS E., JAURRIETA E. - Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg, 2001, 88, 980-5.
6. BUTLER J., ATTIYEH F.F., DALY J.M. - Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet, 1986, 162, 109-13.
7. CURLEY S.A., ROH M.S., CHASE J.L., HOHN D.C. - Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg, 1993, 166, 743-6, discussion 746-8.
8. NONAMI T., TAKEUCHI Y., YASUI M. et al. - Regional adjuvant chemotherapy after partial hepatectomy for metastatic colorectal carcinoma. Semin Oncol, 1997, 24, S6-130-S6-134.
9. PATT Y.Z., MCBRIDE C.M., AMES F.C. et al. - Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer, 1987, 59, 867-73.
10. PORTE H., DE MOULINS H., GAMBIEZ L., WURTZ A., QUANDALLE P. - A pilot study of adjuvant hepatic arterial infusion chemotherapy, associating 5-fluorouracil and leucovorin, after resection of colorectal cancer liver metastases. Surg Oncol, 1995, 4, 317-22.
11. OKUNO K., YASUTOMI M., HIDA J., et al. - Longterm effects of hepatic arterial interleukin-2-based immunochemotherapy after potentially curative resection of colorectal liver metastases. J Am Coll Surg, 1998, 187, 271-5.
12. ASAHARA T., KIKKAWA M., OKAJIMA M. et al. - Studies of postoperative transarterial infusion chemotherapy for liver metastasis of colorectal carcinoma after hepatectomy. Hepatogastroenterology, 1998, 45, 805-11.
13. BERLIN J., MERRICK H.W., SMITH T.J., LERNER H. - Phase II evaluation of treatment of complete resection of hepatic metastases from colorectal cancer and adjuvant hepatic arterial infusion of floxuridine : an Eastern Cooperative Oncology Group Study (PB083). Am J Clin Oncol, 1999, 22, 291-3.
14. LORENZ M., MULLER H.H., SCHRAMM H., et al. - Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases. Ann Surg, 1998, 228, 756-62.
15. KEMENY M.M., ADAK S., GRAY B., et al. - Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver : surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J Clin Oncol, 2002, 20, 1499-505.
16. KEMENY N., HUANG Y., COHEN A.M., et al. - Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med, 1999, 341, 2039-48.
17. WAGMAN L.D., KEMENY M.M., LEONG L., et al. - A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol, 1990, 8, 1885-93.
18. LYGIDAKIS N.J., ZIRAS N., PARISSIS J. - Resection versus resection combined with adjuvant pre-and post- operative chemotherapy-immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology, 1995, 42, 155-61.
19. RUDROFF C., ALTENDORF-HOFFMANN A., STANGL R., SCHEELE J. - Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after RO resection of colorectal liver metastases. Langenbecks Arch Surg, 1999, 384, 243-9.
20. TONO T., HASUIKE Y., OHZATO H., TAKATSUKA Y., KIKKAWA N. - Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases : A randomized study. Cancer, 2000, 88, 1549-56.
21. VENOOK A.P., ALTHAUS B., WARREN R.S. - Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer. N Engl J Med., 2000, 342, 1524, author reply 1526-7.
22. ATKINS C.D. - Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer. N Engl J Med, 2000, 342, 1524-5, author reply 1526-7.
23. CONROY T., MARCHAL F., BRIANCON S. - Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer. N Engl J Med., 2000, 342, 1525, author reply 1526-7.
24. LORENZ M., HOCHMUTH K., MULLER HH. - Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer. N Engl J Med., 2000, 342, 1525-6, author reply 1526-7.
25. LYGIDAKIS N.J., SGOURAKIS G., VLACHOS L. et al. - Metastatic liver disease of colorectal origin : the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study. Hepatogastroenterology, 2001, 48, 1685-91.
26. PORTIER G., ROUGIER P., MILAN C. et al. - Adjuvant systemic chemotherapy (CT) using 5-fluorouracil (FU) and folinic acid (FA) after resection of liver metastases (LM) from colorectal (CRC) origin. Results of an intergroup phase III study (trial FFCD - ACHBTH - AURC 9002). Proc Am Soc Clin Oncol, 2002, 21, 133a.
27. LANGER B., BLEIBERG H., LABIANCA R., et al. - Fluorouracil (FU) plus 1-leucovorin (1-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC) : results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. Proc Am Soc Clin Oncol, 2002, 21, 149a.
28. DE GRAMONT A., BOSSET J.F., MILAN C, et al. - Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer : a French intergroup study. J Clin Oncol, 1997, 15, 808-815.
29. ANDRÉ T., COLIN P., LOUVET C, et al. - Phase III trial (GERCOR C96.1) comparing bimonthly LV5FU2 to monthly 5FU-leucovorin high dose (LVHD) for 24 or 36 weeks in patients with Dukes' B2 and C colon cancer. First report of efficacy. Proc Am Soc Clin Oncol, 2002, 21, 133a.
30. BISMUTH H., ADAM R., LEVI F. et al. - Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg, 1996, 224, 509-20, discussion 520-2.
31. GIACCHETTI S., ITZHAKI M., GRUIA G., et al. - Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol, 1999, 10, 663-9.
32. ADAM R., AVISAR E., ARICHE A., et al. - Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol, 2001, k, 347-53.
33. COPUR M.S., CAPADANO M., LYNCH J., et al. - Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer : a phase II trial using intermittent percutaneous hepatic arterial access. J Clin Oncol, 2001, 19, 2404-12.
34. LORENZ M., MUELLER H.H, MATTES E., et al. - Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas. Ann Oncol, 2001, 8, 321-5.
35. RIVOIRE M., ELIAS D., DE CIAN F., KAEMMERLEN P., THEODORE C., DROZ J.P. - Multimodality treatment of patients with liver metastases from germ cell tumors : the role of surgery. Cancer, 2001, 92, 578-87.
36. HAHN T.L., JACOBSON L., EINHORN L.H., FOSTER R., GOULET R.J., JR. - Hepatic resection of metastatic testicular carcinoma : a further update. Ann Surg Oncol, 1999, 6, 640-4.
37. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. Meta-Analysis Group in Cancer. J Natl Cancer Inst, 1996, 88, 252-8.
38. SALTZ L.B., COX J.V., BLANKE C., et al. - Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med, 2000, 343, 905-14.
39. WANG F.S., ASCHELE C., SOBRERO A., CHANG Y.M., BERTINO JR. - Decreased folylpolyglutamate synthetase expression : a novel mechanism of fluorouracil resistance. Cancer Res, 1993, 53, 3677-80.
40. YANG Y., FORSLUND A., REMOTTI H., et al. - P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection. Cancer, 2001, 91, 727-36.
41. LEICHMAN C.G., LENZ H.J, LEICHMAN L., et al. - Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted - infusion fluorouracil and weekly leucovorin. J Clin Oncol, 1997, 15, 3223-9.